Literature DB >> 8813465

Somatostatin receptor scintigraphy in non-medullary thyroid cancer.

P T Postema1, W W De Herder, J C Reubi, H Y Oei, D J Kwekkeboom, H J Bruining, J Bonjer, H van Toor, G Hennemann, E P Krenning.   

Abstract

8 patients with papillary cancer (4 with metastases, 4 in remission), 7 follicular cancer patients (6 with metastases), 2 patients with anaplastic thyroid cancer and 4 other non-medullary thyroid cancer patients all received an intravenous bolus injection of 220 MBq [111In-DTPA-D-Phe1]octreotide. Planar anterior and posterior gamma camera images of head-neck, chest and abdomen were obtained 24 and 48 h after injection. All primary cancers showed [111In-DTPA-D-Phe1] octreotide uptake; none occurred in patients in remission. The results were compared with conventional radio-iodine scintigraphy in patients with metastasised, differentiated thyroid cancer.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8813465     DOI： 10.1159/000201391

Source DB:  PubMed          Journal:  Digestion        ISSN： 0012-2823            Impact factor:   3.216


  10 in total

Review 1.  Octreoscan radioreceptor imaging.

Authors:  Aart J van der Lely; Wouter W de Herder; Eric P Krenning; Dik J Kwekkeboom
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

2.  Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic value.

Authors:  Marcel P M Stokkel; Robbert B Verkooijen; Jan W A Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-26       Impact factor: 9.236

3.  Exploring new frontiers in molecular imaging: Emergence of Ga PET/CT.

Authors:  Eik Hock Tan; Soon Whatt Goh
Journal:  World J Radiol       Date:  2010-02-28

4.  Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer.

Authors:  L M Haslinghuis; E P Krenning; W W De Herder; A E Reijs; D J Kwekkeboom
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

5.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 6.  Somatostatin receptor SPECT.

Authors:  Giovanna Pepe; Roy Moncayo; Emilio Bombardieri; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 7.  Peptide Receptor Radionuclide Therapy in Thyroid Cancer.

Authors:  Sriram Gubbi; Christian A Koch; Joanna Klubo-Gwiezdzinska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

8.  Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.

Authors:  Marcel P M Stokkel; Henna I E Reigman; Robbert B T Verkooijen; Jan W Smit
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-15       Impact factor: 4.553

9.  Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid.

Authors:  L E Tisell; H Ahlman; B Wängberg; L Kölby; M Fjälling; E Forssell-Aronsson; J Mölne; O Nilsson
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

10.  The relevance of somatostatin receptors in thyroid neoplasia.

Authors:  H Ahlman; L E Tisell; B Wängberg; M Fjälling; E Forssell-Aronsson; L Kölby; O Nilsson
Journal:  Yale J Biol Med       Date:  1997 Sep-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.